For a 46‑year‑old male with type 3c diabetes, weight 88 kg, impaired renal function, currently taking 10 units of Lantus (insulin glargine) daily with an insulin sensitivity factor of 50 mg/dL per unit and an insulin‑to‑carbohydrate ratio of 10 g per unit, and having blood glucose readings of 263 mg/dL at 5 pm and 231 mg/dL at 2 am after meals of 80 g, 82 g, and 34 g carbohydrate, what should his Lantus dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be?

Insulin Dose Adjustment Recommendations

Increase your Lantus dose to 12 units daily (a 20% increase from current 10 units), tighten your insulin-to-carbohydrate ratio to 1:8 (from 1:10), and adjust your insulin sensitivity factor to 40 mg/dL per unit (from 50). Your persistent hyperglycemia despite consuming 196g of carbohydrates with only modest glucose elevation suggests inadequate basal coverage and suboptimal prandial dosing.

Rationale for Basal Insulin Adjustment

Your overnight glucose pattern reveals the core problem: you started at 263 mg/dL at 5 PM and remained at 231 mg/dL at 2 AM despite eating three substantial meals totaling 196g carbohydrates. This minimal 32 mg/dL drop over 9 hours with significant carbohydrate intake indicates your basal insulin is grossly insufficient.

According to the 2025 ADA Standards, basal insulin should be titrated by increasing 2 units every 3 days until fasting plasma glucose goals are achieved without hypoglycemia 1. Your current 10 units represents the minimum starting dose for type 2 diabetes 2, but type 3c diabetes often requires more aggressive insulin therapy due to combined endocrine and exocrine pancreatic dysfunction 3.

Start with a 20% increase (2 units) to 12 units of Lantus daily. Continue increasing by 2 units every 3 days until your fasting and pre-meal glucose readings consistently fall below 130 mg/dL 1. Your GFR of 77 mL/min represents mild renal impairment, which actually increases insulin requirements for glargine compared to more severe dysfunction 4—at your level of renal function, dose reduction is not yet warranted.

Prandial Insulin Ratio Adjustments

Insulin-to-Carbohydrate Ratio (ICR)

Your current 1:10 ratio is too lenient. You consumed 196g of carbohydrates across three meals, which at 1:10 should have required 19.6 units of rapid-acting insulin. Yet your glucose only dropped 32 mg/dL overnight—this suggests either you're not taking enough prandial insulin or your ratio needs tightening.

Adjust to 1:8 (one unit per 8g carbohydrate). This represents a 25% increase in prandial insulin dosing. For your meal pattern:

• 80g CHO meal = 10 units (vs. 8 units previously)
• 82g CHO meal = 10.3 units (vs. 8.2 units previously)
• 34g CHO meal = 4.3 units (vs. 3.4 units previously)

Insulin Sensitivity Factor (ISF)

Your ISF of 50 mg/dL per unit is too conservative for someone with persistent hyperglycemia. Tighten to 40 mg/dL per unit. This means:

• At 263 mg/dL (assuming target of 120 mg/dL): correction dose = (263-120)/40 = 3.6 units
• Previously at ISF 50: correction dose would have been only 2.9 units

This 24% increase in correction dosing will help address persistent hyperglycemia more aggressively.

Type 3c Diabetes Considerations

Type 3c diabetes presents unique challenges that justify more aggressive insulin therapy 3, 5:

• Both endocrine and exocrine insufficiency: Ensure you're on pancreatic enzyme replacement therapy (PERT), as malabsorption affects carbohydrate metabolism unpredictably
• Greater glucose variability: Your relatively stable overnight glucose despite large carbohydrate intake is atypical and suggests impaired counter-regulatory responses (glucagon deficiency)
• Higher hypoglycemia risk: Monitor closely with these adjustments, but your current hyperglycemia indicates you're far from this concern

Renal Function Impact

Your GFR of 77 mL/min with creatinine 1.18 represents Stage 2 CKD. Research shows that insulin glargine requirements actually correlate positively with renal function—dose reductions typically aren't needed until GFR drops below 60 mL/min 4. At your current level, standard dosing applies, though you should monitor more frequently as renal function may affect insulin clearance unpredictably 2.

Implementation Algorithm

1. Immediately increase Lantus to 12 units at the same time daily 2
2. Apply new ICR of 1:8 starting with your next meal
3. Use ISF of 40 for all correction doses
4. Monitor fasting glucose daily and pre-meal glucose before each meal
5. Increase Lantus by 2 units every 3 days if fasting glucose remains >130 mg/dL 1
6. Reassess ICR and ISF after 1 week of stable basal dosing

Critical Monitoring Points

• Watch for hypoglycemia between 2-4 AM (peak action of evening Lantus) once doses increase
• Verify PERT compliance: Inadequate enzyme replacement will cause erratic carbohydrate absorption
• Check for lipohypertrophy: Rotate injection sites to avoid impaired absorption 6
• Consider continuous glucose monitoring: Type 3c diabetes has high glucose variability that spot checks may miss 5

Common Pitfalls to Avoid

Do not delay titration due to fear of hypoglycemia—your current glucose levels (263 mg/dL) pose greater immediate risk than appropriately titrated insulin. The ADA guidelines emphasize that therapeutic inertia (failure to intensify therapy) is a major barrier to glycemic control 1.

Do not mix or dilute Lantus with other insulins or solutions, as this alters its pharmacokinetic profile unpredictably 2.

Do not assume type 3c diabetes behaves like type 2 diabetes—while oral agents may have some role 7, your presentation with significant hyperglycemia requires insulin as primary therapy 3.